Though IDO1 is also overexpressed by the tumor cells, what has caught the most attention is its overexpression in the DCs that depletes tryptophan in the TME leading to T-cell anergy and immune tolerance by the tumor cells. This evidence concerns the gene IDO1 and neoplasm.